A recent study has unveiled the pivotal role of Ferroptosis Suppressor Protein 1 (FSP1) in intervertebral disc degeneration ...

UPF researchers have led the creation of a computational simulator that is unique in the world to study one of the causes of ...

Intervertebral disc degeneration (IVDD) is a leading cause of chronic back pain and disability, impacting millions of people worldwide. Characterized by the breakdown of the disc’s extracellular ...

With millions of people suffering from chronic back pain, Discure Technologies Ltd. is hoping that its bioelectronic therapy, ...

Other types of back injuries include fracture/compression fractures, degenerative disc disease, disc herniation, radiculopathy, spondylolysis, spondylolisthesis, strain, facet arthritis ...

This is the most common surgery for chronic nonspecific back pain with degenerative changes ... Sometimes a disk, the cushion that separates your vertebrae, can slip out of place, press on ...

If you have been diagnosed with disc degeneration or spinal arthritis, you may have received some temporary relief with ...

Low back pain is the most common cause of disability ... Currently, there is no clinical therapy targeting the reversal of disc degeneration or that addresses intervertebral disc cell homeostasis.

The Food and Drug Administration (FDA) has granted Fast Track designation to BRTX-100 for the treatment of chronic lumbar disc disease, defined as back and/or radicular pain with confirmed ...

Spinal Stabilization Technologies enrolled its first U.S. patient in the Investigational Device Exemption clinical trial for its PerQdisc Nucleus Replacement Device.